IL18R1 and neoplasm: CD4+ T cell-derived secretion of the characteristic tumoricidal cytokine, IFN-γ, has been acknowledged as a read-out of increased anti-tumour CD4+ responses89 and IL-12 also upregulates expression of the IL-18 receptor (IL-18Rα) which leads to enhanced IFN-γ production90.